|
Interaction of the anticancer agent Taxol? (paclitaxel) with phospholipid bilayers
|
journal
|
August 1999 |
|
Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature
|
journal
|
January 2004 |
|
Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes: Targeted Tumor-Selective Thromboses In Vivo
|
journal
|
October 2007 |
|
Vascular targeting by EndoTAG™-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer: Efficient Antitumoral Therapy by EndoTAG™-1
|
journal
|
August 2009 |
Influence of cationic lipids on the stability and membrane properties of paclitaxel‐containing liposomes
- Campbell, Robert B.; Balasubramanian, Sathyamangalam V.; Straubinger, Robert M.
-
Journal of Pharmaceutical Sciences, Vol. 90, Issue 8
https://doi.org/10.1002/jps.1063
|
journal
|
August 2001 |
|
Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics
|
journal
|
February 2009 |
|
Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect**Štěpán Koudelka and Pavlína Turánek-Knötigová contributed equally to this work.
|
journal
|
May 2010 |
|
Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties
|
journal
|
June 2010 |
|
Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer
|
journal
|
February 2006 |
|
Paclitaxel chemotherapy for the treatment of gastric cancer
|
journal
|
June 2009 |
|
Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells
|
journal
|
September 2007 |
|
Lipid nanoparticle delivery systems for siRNA-based therapeutics
|
journal
|
June 2013 |
|
Patisiran: First Global Approval
|
journal
|
September 2018 |
|
Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles
|
journal
|
March 1990 |
|
Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia
|
journal
|
October 1996 |
|
Structure and design of polymeric surfactant-based drug delivery systems
|
journal
|
June 2001 |
|
Cremophor EL
|
journal
|
September 2001 |
|
Liposomal drug delivery systems: From concept to clinical applications
|
journal
|
January 2013 |
|
Preclinical and clinical development of siRNA-based therapeutics
|
journal
|
June 2015 |
|
Delivery of oligonucleotides with lipid nanoparticles
|
journal
|
June 2015 |
|
Co-delivery of drugs and plasmid DNA for cancer therapy
|
journal
|
March 2016 |
|
The battle of “nano” paclitaxel
|
journal
|
December 2017 |
|
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
|
journal
|
October 2006 |
|
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
|
journal
|
September 2010 |
|
Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies
|
journal
|
November 2017 |
|
Synthesis of linear and cyclic peptide–PEG–lipids for stabilization and targeting of cationic liposome–DNA complexes
|
journal
|
March 2016 |
|
A critical review of lipid-based nanoparticles for taxane delivery
|
journal
|
July 2013 |
|
Nanoparticle-siRNA: A potential cancer therapy?
|
journal
|
February 2016 |
|
Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation
|
journal
|
January 2005 |
|
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
|
journal
|
June 2007 |
|
Paclitaxel: What has been done and the challenges remain ahead
|
journal
|
June 2017 |
|
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
|
journal
|
July 2007 |
|
Non-viral is superior to viral gene delivery
|
journal
|
November 2007 |
|
Improvement of drug safety by the use of lipid-based nanocarriers
|
journal
|
October 2012 |
|
Liposomal paclitaxel formulations
|
journal
|
November 2012 |
|
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
|
journal
|
October 2016 |
|
Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy
|
journal
|
December 2017 |
|
RNAi and small interfering RNAs in human disease therapeutic applications
|
journal
|
November 2010 |
|
Paclitaxel Crystal Seeds with Different Intrinsic Properties and Their Impact on Dissolution of Paclitaxel-HPMCAS Amorphous Solid Dispersions
|
journal
|
February 2018 |
|
Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review
|
journal
|
March 2016 |
|
Formation of Highly Structured Cubic Micellar Lipid Nanoparticles of Soy Phosphatidylcholine and Glycerol Dioleate and Their Degradation by Triacylglycerol Lipase
|
journal
|
May 2014 |
|
Recent Advances in Nonviral Vectors for Gene Delivery
|
journal
|
August 2011 |
|
Taxol-Lipid Interactions: Taxol-Dependent Effects on the Physical Properties of Model Membranes
|
journal
|
August 1994 |
|
Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
|
journal
|
May 1971 |
|
A Columnar Phase of Dendritic Lipid−Based Cationic Liposome−DNA Complexes for Gene Delivery: Hexagonally Ordered Cylindrical Micelles Embedded in a DNA Honeycomb Lattice
|
journal
|
March 2006 |
|
Highly Efficient Gene Silencing Activity of siRNA Embedded in a Nanostructured Gyroid Cubic Lipid Matrix
|
journal
|
December 2010 |
|
Emerging Frontiers in Drug Delivery
|
journal
|
January 2016 |
|
Nanogyroids Incorporating Multivalent Lipids: Enhanced Membrane Charge Density and Pore Forming Ability for Gene Silencing
|
journal
|
June 2011 |
|
Mechanism of Macromolecular Structure Evolution in Self-Assembled Lipid Nanoparticles for siRNA Delivery
|
journal
|
April 2014 |
|
Promotion of microtubule assembly in vitro by taxol
|
journal
|
February 1979 |
|
Liposomes derived from molecular vases
|
journal
|
September 2012 |
|
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
|
journal
|
January 2017 |
|
Microtubules as a target for anticancer drugs
|
journal
|
April 2004 |
|
RNA interference in the clinic: challenges and future directions
|
journal
|
December 2010 |
|
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
|
journal
|
February 2017 |
|
Delivery technologies for genome editing
|
journal
|
March 2017 |
|
Recent advances with liposomes as pharmaceutical carriers
|
journal
|
February 2005 |
|
Non-viral vectors for gene-based therapy
|
journal
|
July 2014 |
|
Progress and challenges towards targeted delivery of cancer therapeutics
|
journal
|
April 2018 |
|
Cationic liposome–nucleic acid complexes for gene delivery and gene silencing
|
journal
|
January 2014 |
|
Paclitaxel Encapsulated in Cationic Liposomes Diminishes Tumor Angiogenesis and Melanoma Growth in a “Humanized” SCID Mouse Model
|
journal
|
March 2003 |
|
Paclitaxel (Taxol)
|
journal
|
April 1995 |
|
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
|
journal
|
October 1993 |
|
Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
|
journal
|
April 1999 |
|
How Taxol/paclitaxel kills cancer cells
|
journal
|
September 2014 |
|
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
|
journal
|
April 2012 |
|
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
|
journal
|
April 2014 |
|
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
|
journal
|
November 2015 |
|
Polyunsaturated Fatty Acid-Induced Cytotoxicity Against Tumor Cells and Its Relationship to Lipid Peroxidation
|
journal
|
April 1988 |
Cationic liposome–nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing
- Majzoub, Ramsey N.; Ewert, Kai K.; Safinya, Cyrus R.
-
Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, Vol. 374, Issue 2072
https://doi.org/10.1098/rsta.2015.0129
|
journal
|
July 2016 |
|
Two-Dimensional Smectic Ordering of Linear DNA Chains in Self-Assembled DNA-Cationic Liposome Mixtures
|
journal
|
September 1997 |
|
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
|
journal
|
May 2016 |
|
Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes
|
journal
|
February 1997 |
|
An Inverted Hexagonal Phase of Cationic Liposome-DNA Complexes Related to DNA Release and Delivery
|
journal
|
July 1998 |
|
A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect
|
journal
|
October 2011 |
|
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
|
journal
|
April 1998 |
|
Pharmacology and Toxicology of Cremophor EL Diluent
|
journal
|
May 1994 |
|
Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective
|
journal
|
October 2014 |
|
Hypersensitivity reactions from taxol.
|
journal
|
July 1990 |
|
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
|
journal
|
November 2005 |
|
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
|
journal
|
July 2015 |
|
Pharmacokinetics of paclitaxel-containing liposomes in rats
|
journal
|
December 2003 |
|
Paclitaxel in cancer therapy
|
journal
|
June 2002 |
|
Paclitaxel for non-small cell lung cancer
|
journal
|
August 2004 |
|
Cationic lipid–DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways
|
journal
|
January 2005 |
|
Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics
|
journal
|
January 2012 |
|
Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents
|
journal
|
October 2010 |
|
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation
|
journal
|
January 2016 |
|
Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment
|
journal
|
January 2016 |
|
Optimization of drug loading to improve physical stability of paclitaxel-loaded long-circulating liposomes
|
journal
|
December 2014 |
|
Advances and Challenges of Liposome Assisted Drug Delivery
|
journal
|
December 2015 |
|
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol
|
journal
|
June 2018 |
|
Paclitaxel Nano-Delivery Systems: A Comprehensive Review
|
journal
|
January 2013 |
|
Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges
|
journal
|
August 2012 |